Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets worldwide. The company commercializes approximately thirty proprietary evidence-based finished products. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids...
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Address:
480 University Avenue, Suite 1502, Toronto, Canada
